BioXcel Therapeutics, Inc. Leasehold Improvements, Gross
BioXcel Therapeutics, Inc. (BTAI) had Leasehold Improvements, Gross of $642.00 thousand as of 2019-02-22, per its 10-Q filed 2020-08-14.
Discontinued › Balance Sheet › Assets
us-gaap:LeaseholdImprovementsGross · last filed 2020-08-14
- 2019-02-22: Leasehold Improvements, Gross $642.00K; Leasehold Improvements, Gross as first filed $587.00K.
| Period end | Leasehold Improvements, Gross | Leasehold Improvements, Gross as first filed |
|---|---|---|
| 2019-02-22 | $642.00K 10-Q · filed 2020-08-14 | $587.00K 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |